Effect of Acute Caffeine and Beetroot Juice Intake on Strength, Power, and Muscular Endurance (CAF+BJ)

September 10, 2024 updated by: Alberto Pérez-López, University of Alcala

Effect of Acute Caffeine and Beetroot Juice Intake on Strength, Power, and Muscular Endurance Based on Circadian Rhythms.

Introduction: Several studies have evaluated and confirmed the ergogenic effect of acute caffeine and beetroot juice intake on sports performance. However, there are few studies focused on the production of strength, power, and muscle endurance, particularly when both supplements are ingested together.

Objectives: Evaluate the acute effect of combined and isolated intake of caffeine and beetroot juice on the production of strength, power, and muscle endurance in young adults, analyzing the effect of circadian rhythms (morning vs. afternoon) on the exercise performed (bench press vs. squat).

Methods: A total of 12 healthy and physically active participants will be recruited for the study. Through a double-blind, crossover, randomized, and controlled design, participants will ingest: a) Caffeine (3 mg/kg body mass); b) Beetroot juice (70 ml, 6.5 mmol of nitrates); c) Caffeine + Beetroot juice; d) Placebo (maltodextrin, 3 mg/kg). The supplements will be ingested 120 minutes (beetroot juice or placebo) and 60 minutes before (caffeine or placebo), the latter dissolved in 200 ml of water. After the ingestion period, strength, power, and muscle endurance will be analyzed with 1RM tests, strength and power tests at 25%, 50%, 75%, and 90% 1RM, and muscle endurance tests at 65% 1RM, in all cases for squat and bench press exercises. Additionally, dynamometry (manual and the isometric mid-thigh pull test) and vertical jump (squat jump and countermovement jump) will be analyzed. The four experimental conditions will be conducted in the morning (8:00 am to 10:00 am) and in the afternoon (4:30 pm to 6:30 pm).

Study Overview

Study Type

Interventional

Enrollment (Actual)

14

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Madrid
      • Alcalá de Henares, Madrid, Spain, 28805
        • Facultad de Medicina y Ciencias de la Salud. Universidad de Alcalá

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age between ≥ 18 and ≤ 35 years.
  • Body Mass Index (BMI) < 25 kg/m².
  • Resistance-trained individuals (> 2 years of structured trained).
  • Healthy men and women without neurological, cardiometabolic, immunological, or physical conditions that prevent them from exercising.
  • Participants must be able to perform the tests described in the following section.

Exclusion Criteria:

  • History of neuromuscular diseases, heart diseases, or diseases that may affect liver or muscle metabolism.
  • Use of drugs, other stimulants or sport supplements that interfere with the intake of the study's dietary supplements.
  • Sedentary habits (< 150 min/week of moderate exercise).
  • Having undergone prolonged periods of forced physical inactivity during the 6 months prior to the study.
  • Performing strenuous exercise during the 48 hours prior to the tests.
  • Failure to replicate the same food intake on the two days of the experiments.
  • Consuming caffeine or any other stimulant after 6 pm the day before the training or tests, to avoid headaches, discomfort, or lethargy among regular caffeine consumers.
  • Consuming foods rich in NO3- (e.g., beetroot, spinach, or celery) during the 48 hours prior to each experimental condition.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Caffeine + Beetroot Juice
70 mL of concentrated NO3--rich (BJ, 6.5 mmol NO3-) + 3 mg/kg of caffeine
Combined effect of beetroot juice and caffeine intake on muscular strength, power and endurance performance
Experimental: Beetroot Juice
70 mL of concentrated NO3--rich (BJ, 6.5 mmol NO3-) + 3 mg/kg of placebo (maltodextrin)
single effect of beetroot juice intake on muscular strength, power and endurance performance
Experimental: Caffeine
70 mL of NO3--depleted (BJ, 0.04 mmol NO3-) + 3 mg/kg of caffeine
single effect of caffeine intake on muscular strength, power and endurance performance
Placebo Comparator: Placebo
70 mL of NO3--depleted (BJ, 0.04 mmol NO3-) + 3 mg/kg of placebo (maltodextrin)
single effect of placebo on muscular strength, power and endurance performance

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean and peak velocity and time to reach peak velocity at different %1RM
Time Frame: On each trial, after dietary supplement intake, during 2 weeks
Measuring bar velocity desplacement during bench press and back squat exercises.
On each trial, after dietary supplement intake, during 2 weeks
Mean and peak power output and time to reach peak power output at different %1RM
Time Frame: On each trial, after dietary supplement intake, during 2 weeks
Measuring power output generated during bench press and back squat exercises.
On each trial, after dietary supplement intake, during 2 weeks
Number of repetitions performed at 65%1RM until task failure
Time Frame: On each trial, after dietary supplement intake, during 2 weeks
Additionally to mean and peak velocity, mean and peak power output, time to reach peak velocity and peak power
On each trial, after dietary supplement intake, during 2 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mood state (tension, depression, anger, vigor, fatigue and confusion)
Time Frame: On each trial, after dietary supplement intake, during 2 weeks
Participants graded a set of 29 items related to the mood on a Likert scale from 0 (not at all) to 4 (extremely) in reply to the question "How do you feel at this moment?" to assess six scales: tension, depression, anger, vigor, fatigue and confusion.
On each trial, after dietary supplement intake, during 2 weeks
Adverse effects
Time Frame: On each trial, after dietary supplement intake, during 2 weeks
perception of power, endurance, energy and exertion, as well as heart, muscular and gastrointestinal discomfort.
On each trial, after dietary supplement intake, during 2 weeks
handgrip and isometric mid-thigh pull tests
Time Frame: On each trial, after dietary supplement intake, during 2 weeks
N generated
On each trial, after dietary supplement intake, during 2 weeks
Vertical Jump (cm and power)
Time Frame: On each trial, after dietary supplement intake, during 2 weeks
On each trial, after dietary supplement intake, during 2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2023

Primary Completion (Actual)

January 30, 2024

Study Completion (Actual)

May 1, 2024

Study Registration Dates

First Submitted

September 6, 2024

First Submitted That Met QC Criteria

September 10, 2024

First Posted (Estimated)

September 19, 2024

Study Record Updates

Last Update Posted (Estimated)

September 19, 2024

Last Update Submitted That Met QC Criteria

September 10, 2024

Last Verified

September 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Nitrates

Clinical Trials on Acute caffeine and beetroot juice

Subscribe